Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12083107 Pharmaceutical compositions comprising glitazones and Nrf2 activators

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
October 26, 2022
0
Date of Patent
September 10, 2024
0
Patent Application Number
18049652
0
Patent Citations
‌
US Patent 8129429 Synthetic triterpenoids and methods of use in the treatment of disease
0
‌
US Patent 6858750 Use of fumaric acid derivatives for treating mitochondrial diseases
0
‌
US Patent 7157423 Fumaric acid amides
0
‌
US Patent 7223761 Salts and polymorphs of a potent antidiabetic compound
0
‌
US Patent 7320999 Dimethyl fumarate for the treatment of multiple sclerosis
0
‌
US Patent 7435755 CDDO-compounds and combination therapies thereof
0
‌
US Patent 7601841 Quinolinyl and benzothiazolyl modulators
0
‌
US Patent 7619001 Utilization of dialkylfumarates
0
‌
US Patent 7803840 Utilization of dialkylfumarates
0
‌
US Patent 7976853 Process for producing coated preparation
0
•••
Patent Inventor Names
Bjoern Colin Kahrs
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12083107
0
Patent Primary Examiner
‌
Sun Jae Yoo
0
CPC Code
‌
A61K 31/12
0
‌
A61K 31/16
0
‌
A61K 31/19
0
‌
A61K 31/216
0
‌
A61K 31/225
0
‌
A61K 31/26
0
‌
A61K 31/385
0
‌
A61K 31/426
0
‌
A61K 31/47
0
‌
Y02A 50/30
0
•••

Find more entities like US Patent 12083107 Pharmaceutical compositions comprising glitazones and Nrf2 activators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo